Viewing Study NCT01890135


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-03-02 @ 4:01 PM
Study NCT ID: NCT01890135
Status: COMPLETED
Last Update Posted: 2016-08-02
First Post: 2013-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zibotentan, an Endothelin Receptor Antagonist, Patients With Intermittent Claudication
Sponsor: University of Virginia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module